Author: Todd Wyche

Companies in emerging industries such as the life sciences are constantly looking for funding, but uncertainty in the capital markets has made this a time-sensitive, challenging and expensive process to execute. The capital markets, particularly over the last few years, and especially for research and development-intensive biopharmaceutical companies, have been unpredictable, making timing of financings … Continue reading “Raising Capital At-The-Market: a Prescription for a Solid Long-Term Financing Strategy”